Two noteworthy insider buys occurred on Tuesday. Strive’s CEO, Matthew Ryan Cole, purchased 500,000 shares of ASST at $0.92 each, totaling $459,350. ASST reached a high of $1.07, up 16.5% from Cole’s buy. Strive’s stock is up 5.8% on Wednesday. In a separate transaction, Director David J. Matlin bought 33,333 shares of Clene at $6.50 each, totaling $216,664. Clene is trading 1.7% lower on Wednesday, offering investors a price 23.8% below Matlin’s purchase price at $4.95. This marks Matlin’s first buy in the past year.

Read more at Nasdaq, Inc.: Wednesday 1/14 Insider Buying Report: ASST, CLNN